DalsnaFinance › IPOs › MBX Biosciences, Inc.
MBX Biosciences, Inc. completed its initial public offering on NASDAQ on September 13, 2024, pricing at $16.00 a share.
| Ticker | MBX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | September 13, 2024 |
| Offering price | $16.00 |
| Shares offered | 10,200,000 |
| Total raised | $163M |
MBX Biosciences, Inc. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.